Ina M. Jürgenliemk‐Schulz

Author

Also Known As

I Jrgenliemk-Schulz, I Jurgenliemk-Schulz, I Jürgenliemk-Schulz, I M Jürgenliemk-Schulz, I. Jurgenliemk-Schulz, I. Jürgenliemk-Schulz, I.M. Jürgenliemk-Schulz, Ina Jurgenliemk-Schulz, Ina Jürgenliemk-Schulz, Ina Jürgenliemk-Schulz MD, PhD

226

Publications

12.6K

Citations

H-Index

Concepts

All Affiliations

University Medical Center Utrecht Leiden University Medical Center Institut Gustave Roussy Aarhus University Hospital Medical University of Vienna

About

Ina M. Jürgenliemk‐Schulz is an author at University Medical Center Utrecht specializing in radiation oncology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	68	7.4K
2	Health Sciences	32	47	6K
3	Public Health	7	7	383
4	Engineering	2	2	144
5	Gastroenterology	1	1	31

Ina M. Jürgenliemk‐Schulz

109

Publications

10.3K

Citations

H-Index

Page 1

	Year	Citations
Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study Alina Sturdza, Richard Pötter, Lars Fokdal, Radiotherapy and Oncology Advanced Cervical CancerCervical CancerRadiation TherapyMedical ImagingMedicine	2016	680
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial Stephanie M. de Boer, Melanie Powell, Linda Mileshkin, The Lancet Oncology	2018	599
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study Richard Pötter, Kari Tanderup, Maximilian Schmid, The Lancet Oncology Adaptive RadiotherapyAdvanced Cervical CancerCervical CancerMedical ImagingRadiation Therapy	2021	583
Adaptive radiotherapy: The Elekta Unity MR-linac concept Dennis Winkel, Gijsbert H. Bol, P.S. Kroon, Clinical and Translational Radiation Oncology Adaptive RadiotherapyMedical ImagingRadiation TherapyMedicineRadiation Therapy Planning	2019	558
First patients treated with a 1.5 T MRI-Linac: clinical proof of concept of a high-precision, high-field MRI guided radiotherapy treatment Bas W. Raaymakers, Ina M. Jürgenliemk‐Schulz, G.H. Bol, Physics in Medicine and Biology Radiotherapy TreatmentSurgeryNeuro-oncologyOncologyT Mri Functionality	2017	521
Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiotherapy for the Definitive Treatment of Cervix Cancer Karen Lim, William Small, Lorraine Portelance, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyCervical CancerMedical ImagingRadiation TherapyMedicine	2010	448
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial Stephanie M. de Boer, Melanie Powell, Linda Mileshkin, The Lancet Oncology	2019	432
Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer – A pooled analysis of PORTEC 1 and 2 trials Tjalling Bosse, Elke E.M. Peters, Carien L. Creutzberg, European Journal of Cancer A Pooled AnalysisPortec 1Gynecological SurgeryMedicineCancer Management	2015	407
Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer Kari Tanderup, Lars Fokdal, Alina Sturdza, Radiotherapy and Oncology Adaptive RadiotherapyAdvanced Cervical CancerLocal ControlSurgical OncologyCervical Cancer	2016	346
Quality of Life After Pelvic Radiotherapy or Vaginal Brachytherapy for Endometrial Cancer: First Results of the Randomized PORTEC-2 Trial Remi A. Nout, Hein Putter, Ina M. Jürgenliemk‐Schulz, Journal of Clinical Oncology Quality Of LifeSurgical OncologyRadiation TherapyMedicineCancer Management	2009	269

Page 1